| 产品描述: | AZ13824374 is a potent and selective ATAD2 bromodomain inhibitor (pIC50 of 6.9 in HCT116 cells). AZ13824374 disrupts chromatin interactions and gene transcription by binding to the acetyl-lysine binding site of the ATAD2 bromodomain. AZ13824374 has anticancer activity against breast cancer. |
| 体内研究: |
AZ13824374 (0.01-10 µM;14-21 天) 在乳腺癌细胞系 (包括 EVSA-T、SK-BR-3、T-47D 和 MDA-MB-468) 中表现出浓度依赖性的抗增殖活性。 |
| 保存条件: |
-80°C 12个月; -20°C 6个月,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.777 ml |
8.886 ml |
17.772 ml |
| 5 mM |
0.355 ml |
1.777 ml |
3.554 ml |
| 10 mM |
0.178 ml |
0.889 ml |
1.777 ml |
| 50 mM |
0.036 ml |
0.178 ml |
0.355 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |